Scopus by Title (Ref)

Real-World Experience, Effectiveness, and Safety of Direct-Acting Antivirals for the Treatment of Hepatitis C in Oman: A Cross-Sectional, Multicenter Study

Journal of Clinical Medicine

December 2024

Al-Naamani K.M.

Open Access

Biopharmaceutical Production by Recombinant DNA Technology: Future Perspectives

Microbial Products for Health and Nutrition

1 January 2024

Parasuraman S.

Hepatoprotective effects of metformin in hepatitis C virus-infected adolescents with beta thalassaemia major

International Journal of Clinical Practice

December 2021

Talebi A.

Open Access

HCV Infection in Thalassemia Syndromes and Hemoglobinopathies: New Perspectives

Frontiers in Molecular Biosciences

30 January 2020

Maffei L.

Open Access

Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment

Channels

1 January 2020

Alothaid H.

Open Access

Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis

Emerging Microbes and Infections

1 December 2018

Yang C.F.

Open Access

The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C

Journal of the Formosan Medical Association

January 2018

Liang P.C.

Open Access

Generic Direct Acting Antivirals in Treatment of Chronic Hepatitis C Infection in Patients of Thalassemia Major

Journal of Clinical and Experimental Hepatology

September 2017

Nagral A.

All Open Access, Green

Treatment of chronic hepatitis c in thalassemia major patients

Journal of the Pakistan Medical Association

2017

Sajjad S.F.